Altiratinib is a potent inhibitor of TRK kinases and is efficacious in TRK-fusion driven cancer models Meeting Abstract
| Authors: | Smith, B. D.; Leary, C. B.; Turner, B. A.; Kaufman, M. D.; Wise, S. C.; Garcia-Rendueles, M. E. R.; Fagin, J. A.; Flynn, D. L. |
| Abstract Title: | Altiratinib is a potent inhibitor of TRK kinases and is efficacious in TRK-fusion driven cancer models |
| Meeting Title: | 106th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 75 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 Apr 18-22 |
| Meeting Location: | Philadelphia, PA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2015-08-01 |
| Language: | English |
| ACCESSION: | WOS:000371578501243 |
| DOI: | 10.1158/1538-7445.am2015-790 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 790 -- Proceedings of the 106th Annual Meeting of the American Association for Cancer Research -- Source: Wos |
